LHX vs SNOA · P/E 34, rev $5.88B vs rev $19.5M
L3Harris Technologies Inc (LHX) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the LHX and SNOA stock pages for the full models.
Not investment advice.